SEMA7A and ductal breast carcinoma in situ: The cell line that we used for our model, MCF10DCIS, has also been shown to have a population of mammary stem cells (75); as such, blocking SEMA7A could decrease TNFα expression in macrophages and decrease mammary stem cell invasion in our DCIS model.